Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“What was unique in this study was that in the VA, everybody is equal, and everyone gets the same access to drugs.”
In 2009, March was declared Myeloma Awareness Month (MAM).
The PROMISE study aims to identify people with conditions that are precursors of multiple myeloma and track their health over time.
First nuclear export inhibitor gets the nod for patients lacking treatment options.
Here’s a list of the approved drugs to treat multiple myeloma. Click on any of the medications for more info on dosing, side effects...
Darzalex in combination with lenalidomide and dexamethasone is for people who are ineligible for an autologous stem cell transplant.
An advanced study compared intravenous infusions and subcutaneous injections of the antibody treatment.
Around 90% of people treated with the immunomodulator did not develop cancer.
Having health insurance increases early detection and timely treatment for many cancers.
This special issue of Cancer Health focuses on multiple myeloma, a type of blood cancer that affects the bone marrow.
He believes that America has the resources to make drugs and treatment more affordable for everyone.
Their goal is to develop therapies to treat the disease
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.